K-985

Material Data Sheet

UbcH (E2) Enzyme Set, Dominant Negative

Price: $150.00
Catalog #: K-985

UbcH (E2) Enzyme Set, Dominant Negative

Price: 
$150
Quantity: 
1 kit
Data Sheet: 
Stock: 

All proteins supplied in 50mM HEPES, 50mM NaCl, 10% glycerol, 1 mM DTT, pH 8.0

Structure (deprecated): 
Protein MW Quantity
UbcH2 17 kDa 10 μg
His6-UbcH3 26 kDa 10 μg
GST-UbcH5a 43 kDa 10 μg
His6- UbcH6 21 kDa 10 μg
UbcH7 18 kDa 10 μg
His6-UbcH10 20kDa 10 μg
Purity: 
> 95 % by SDS-PAGE

Also known as: UbcH

UbcH2 - This E2 enzyme encodes for the human homolog of the yeast DNA repair gene RAD6, which is induced by DNA damaging agents. UbcH2 can conjugate ubiquitin to histone H2A in an E3-independent manner in vitro, and is essential for the multi-ubiquitination and degradation of N-end rule substrates. Additionally, UbcH2 may have a role in sepsis-induced muscle protein proteolysis and cancer-induced cachexia.

UbcH3 - UbcH3 plays an essential role in the progression of cells from the G1 to S phase of the cell division cycle. One pathway (requiring Cdc34) initiates DNA replication by degrading a CDK (cyclin-dependent kinase) inhibitor. The second pathway, involves the anaphase-promoting complex (APC) initiates chromosome segregation and exit from mitosis by degrading anaphase inhibitors and mitotic cyclins.

UbcH5s - UbcH5 enzymes are human homologs of the yeast UBC4/5 family and play many important regulatory roles in inflammation and cancer. UbcH5a mediates the degradation of a myriad of short-lived regulatory proteins (such as p53 in the presence of E6/E6-AP or MDM2, c-Fos, IκBα, p105) and abnormal proteins. UbcH5a has 89% and 88% sequence identity with UbcH5b and UbcH5c respectively.

UbcH6 - UbcH6 mediates the selective degradation of short-lived and abnormal proteins. The enzyme has high similarity to UbcH5 E2 subfamily, but it does not participate in HECT-domain mediated events.
UbcH7 - UbcH7 mediates the selective degradation of short-lived and abnormal proteins and is highly homologous to UbcH5. UbcH7 interacts with the HECT domain of E6-AP and the RING domain of c-Cbl, and can mediate the multi-ubiquitination of many different types of protein substrates.

UbcH7 - UbcH7 mediates the selective degradation of short-lived and abnormal proteins and is highly homologous to UbcH5. UbcH7 interacts with the HECT domain of E6-AP and the RING domain of c-Cbl, and can mediate the multi-ubiquitination of many different types of protein substrates.

UbcH10- UbcH10 is an essential mediator of mitotic destruction events and cell cycle progression. It catalyzes the destruction of cyclins A and B in conjunction with the anaphasepromoting complex. This activity is essential at then end of mitosis for the inactivation of their partner kinase Cdc2 and exit from mitosis into G1 of the next cell cycle.

Storage: 
Store at -80°C. Avoid multiple freeze/thaw cycles.

Literature

References: 

Baboshina O.V., et al. (2001) J. Biol. Chem. 276:39428-39437
Dohmen J.R., et al. (1991) Proc. Natl. Acad. Sci. 88:7351-7355
Kaiser P., et al. (1995) FEBS. Lett. 377:193-196
Hobler S.C., et al. (1999) Am. J. Physiol. 276:468-473
Wing S.S., et al. (1992) J. Biol. Chem. 267:6495-6501
Goebl M.G., et al. (1988) Science 241:1331-1335
Gonen H., et al. (1999) J. Biol. Chem. 274:14823-14830
King R. W., et al. (1996) Science 274:1652-1659
Listwan J., et al. (1998) EMBO. J. 17:368-383
Pintard L., et al. (2003) Nat. Cell. Biol. 5:856-857
Plon S.E., et al. (1993) Proc. Natl. Acad. Sci. 90:10484-10488
Ptak C., et al. (1994) J. Biol. Chem. 269:26539-26545
Seol J.H., et al. (1999) Gene. Dev. 13:1614-1626
Varelas X., et al. (2003) Mol. Cell. Biol. 23:5388-5400
Jensen J., et al. (1995) J. Biol. Chem. 270:30408-30414
Gehrke S.G., et al. (2003) Blood. 101:3288-3293
Nuber U. And Scheffner M. (1999) J. Biol. Chem. 274:7576-7582
Scheffner M., et al. (1994) Proc. Natl. Acad. Sci. 91:8797-8801
Schwarz S.E., et al. (1998) J. Biol. Chem. 273:12148-12154
Nuber U., et al. (1996) J. Biol. Chem. 271: 2795-800.
Ardley H.C., et al. (1997) Cytogenet. Cell. Genet. 79:188-192
Cook, W.J. (1997) Biochem. (1997) 36:1621-1627
Huang L., et al. (1999) Science 286:1321-1326
Nuber U., et al. (1996) J. Biol. Chem. 271: 2795-2800
Moynihan T.P., et al. (1999) J. Biol. Chem. 241: 30963-30968
Schwarz S.E., et al. (1998) J. Biol. Chem. 273:12148-12154
Zheng N., et al. (2000) Cell 102:533-539
Bastians H., et al. (1999) Mol. Biol. Cell. 10:3927-3941
Hershko A. and Ciechanover A. (1998) Ann. Rev. Biochem. 67:425-479
Lin Y., et al. (2002) J. Biol. Chem. 277:21913-21921
Okamoto Y., et al. (2003) Canc. Res. 63:4167-4173
Townsley F.M., et al. (1997) Proc. Natl. Acad. Sci. 94:2362-2367
Kumar S., et al. (1997) J. Biol. Chem. 272:13548-13554
Nyman T.A., et al. (2000) Eur. J. Biochem. 267:4011-4019
Zhao C., et al. (2004) Proc. Natl. Acad. Sci. 101:7578-7582
Zhang Y., et al. (2000) Proc. Natl. Acad. Sci. 97:13354-13359
Hofmann R.M., et al. (1999) Cell 96:645-653
Hofmann R.M. and Pickart C.M. (2001) J. Biol. Chem. 276:27936-27943
McKenna S., et al. (2001) J. Biol. Chem. 276:40120-40126
McKenna S., et al. (2003) Biochem. 42:7922-7930
Moraes T.F., et al. (2001) Nat. Struc. Biol. 8:669-673
VanDenmark A.P., et al. (2001) Cell. 105:711-720
Yamaguchi T., et al. (1999) J. Biochem. 120:494-497